Cargando…

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

BACKGROUND: Podocalyxin-like 1 (PODXL) is a cell-adhesion glycoprotein and stem cell marker that has been associated with an aggressive tumour phenotype and adverse outcome in several cancer types. We recently demonstrated that overexpression of PODXL is an independent factor of poor prognosis in co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsson, Anna, Fridberg, Marie, Gaber, Alexander, Nodin, Björn, Levéen, Per, Jönsson, Göran, Uhlén, Mathias, Birgisson, Helgi, Jirström, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492217/ https://www.ncbi.nlm.nih.gov/pubmed/22769594 http://dx.doi.org/10.1186/1471-2407-12-282

Ejemplares similares

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
por: Larsson, Anna H., et al.
Publicado: (2016)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma
por: Nodin, Björn, et al.
Publicado: (2012)

Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients
por: Gaber, Alexander, et al.
Publicado: (2010)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
por: Nodin, Björn, et al.
Publicado: (2012)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2018)

Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer Study
por: Jonsson, Liv, et al.
Publicado: (2011)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study
por: Boman, Karolina, et al.
Publicado: (2017)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study
por: Fridberg, Marie, et al.
Publicado: (2012)

High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death
por: Jonsson, Liv, et al.
Publicado: (2014)

Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
por: Berntsson, Jonna, et al.
Publicado: (2014)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
por: Heby, Margareta, et al.
Publicado: (2020)

Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma
por: Fristedt, Richard, et al.
Publicado: (2014)

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer
por: Olofsson, Sven-Erik, et al.
Publicado: (2015)

Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
por: Boman, Karolina, et al.
Publicado: (2013)

Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts
por: Andersson, Gustav, et al.
Publicado: (2014)

Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
por: Berntsson, Jonna, et al.
Publicado: (2018)

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer
por: Gaber, A, et al.
Publicado: (2009)

HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome
por: Bengtsson, Erik, et al.
Publicado: (2014)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2014)

Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer
por: Nodin, Björn, et al.
Publicado: (2012)

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
por: Eberhard, J, et al.
Publicado: (2012)

Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study
por: Brändstedt, Jenny, et al.
Publicado: (2012)

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study
por: Wangefjord, Sakarias, et al.
Publicado: (2011)

Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker
por: Wennersten, Christoffer, et al.
Publicado: (2014)

Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
por: Berntsson, Jonna, et al.
Publicado: (2019)

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression
por: Jonsson, Liv, et al.
Publicado: (2011)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival
por: Svensson, Maria C., et al.
Publicado: (2019)

Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
por: Lundgren, Sebastian, et al.
Publicado: (2019)

The clinical impact of tumour‐infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
por: Berntsson, Jonna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_md5ph5q8nmblufug7jo7dl5b63